Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Answering the Questions on Monkeypox in PWH

Hear from expert faculty as they answer questions and discuss monkeypox treatment and care considerations for people with HIV.
Monica Gandhi, MD, MPH
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Released: December 19, 2022

In this episode, Monica Gandhi, MD, MPH, and Chloe Orkin, MBChB, FRCP, MD, discuss considerations for monkeypox, now called mpox, in people with HIV, including:

  • The history of monkeypox (mpox)
  • The current monkeypox (mpox) outbreak
  • What we knew about monkeypox (mpox) in PWH prior to the current outbreak
  • Data in PWH from an international case series of monkeypox (mpox)
  • CDC data regarding monkeypox (mpox) in PWH
  • Monkeypox (mpox) treatment recommendations
  • Drug–drug interaction considerations between tecovirimat for monkeypox (mpox) and ART
  • Monkeypox (mpox) vaccination recommendations for PWH
  • Global access to monkeypox (mpox) treatments and vaccines
  • Whether monkeypox (mpox) is a sexually transmitted infection and the implications of that
  • Ongoing research on monkeypox (mpox) in PWH

Information on this Educational Activity

Faculty

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.
Chloe Orkin, MBChB, FRCP, MD

Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead Sciences, Janssen, MSD, ViiV Healthcare; researcher: AstraZeneca, Gilead Sciences, Janssen, MSD, ViiV Healthcare.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings